San Luciano, M
Oehrn, C R
Wang, S S
Tolmie, J S
Wiltshire, A
Graff, R E
Zhu, J
Starr, P A
Funding for this research was provided by:
United States National Institutes of Health (UH3NS128297, UH3NS128297, UH3NS128297, UH3NS128297, UH3NS128297, UH3NS128297, UH3NS128297, UH3NS128297)
Article History
Received: 11 March 2024
Accepted: 9 April 2024
First Online: 29 April 2024
Declarations
:
: This trial has been reviewed and approved by the Institutional Review Board (IRB) of the University of California, San Francisco (IRB number 22-37182). This trial has been registered at clinicaltrials.gov (ClinicalTrials.gov ID: NCT06122675, November 7, 2023). Participants will be fully informed about the study procedure and provide written informed consent to participate. This study will be conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.